RETROVIROX, INC.
Biotech · Private
HIV therapeutic approach combining latency-reversing agents with immune-based cell killing to eradicate viral reservoirs
- Grants
- $3.0M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · An immune-based approach for HIV eradication | $1,108,021 | |
| Federal grant | Department of Health and Human Services · Phase II · An immune-based approach for HIV eradication | $1,226,363 | |
| Federal grant | Department of Health and Human Services · Phase II · An immune-based approach for HIV eradication | $665,610 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1885 | Krystal Biotech, Inc. | — | $11M |
| 1886 | SANOSTEM GLOBAL, LLC | — | $3.5M |
| 1887 | Protocol 46 Inc. | — | $410K |
| 1888 | RETROVIROX, INC. | — | — |
| 1889 | Cotinga Pharmaceuticals Inc. | — | $3.0M |
| 1890 | Antlia Bioscience, Inc. | — | $6.9M |
| 1891 | PLEOPHARMA, INC. | — | $17M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Small Molecule Modulators Of Mhc-iapplication
- Small Molecule Modulators Of Mhc-iapplication
- Small Molecule Modulators Of Mhc-iapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.